Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #8 Kura Oncology; Positive Ziftomenib And 7+3 1st-Line AML Data, PDUFA Date November 30th 2025 Ziftomenib Established And ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #11 Vistagen Therapeutics; Q4 Of 2025 Fasediennol SAD Results, IND Filing Of PH80 For Hot Flashes 2nd Half Of 2025 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #11 is a biotech by the name of Vistagen Therapeutics (VTGN). The reason why I want to go over this ...